A detailed history of Manufacturers Life Insurance Company, The transactions in Bio N Tech Se stock. As of the latest transaction made, Manufacturers Life Insurance Company, The holds 20,929 shares of BNTX stock, worth $2.27 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
20,929
Holding current value
$2.27 Million
% of portfolio
0.0%

Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$78.36 - $124.66 $1.64 Million - $2.61 Million
20,929 New
20,929 $2.49 Million
Q2 2023

Aug 11, 2023

SELL
$102.58 - $129.66 $3.59 Million - $4.54 Million
-34,999 Closed
0 $0
Q4 2022

Aug 11, 2023

SELL
$118.43 - $186.05 $2.23 Million - $3.5 Million
-18,832 Reduced 34.98%
34,999 $5.26 Million
Q4 2022

Feb 13, 2023

SELL
$118.43 - $186.05 $2.23 Million - $3.5 Million
-18,832 Reduced 34.98%
34,999 $5.26 Million
Q3 2022

Aug 11, 2023

BUY
$127.65 - $183.11 $755,688 - $1.08 Million
5,920 Added 12.36%
53,831 $7.26 Million
Q3 2022

Nov 03, 2022

BUY
$127.65 - $183.11 $755,688 - $1.08 Million
5,920 Added 12.36%
53,831 $7.19 Million
Q2 2022

Aug 11, 2023

SELL
$123.25 - $186.24 $1.12 Million - $1.69 Million
-9,056 Reduced 15.9%
47,911 $7.14 Million
Q2 2022

Aug 15, 2022

SELL
$123.25 - $186.24 $1.12 Million - $1.69 Million
-9,056 Reduced 15.9%
47,911 $6.8 Million
Q1 2022

Aug 11, 2023

BUY
$126.25 - $231.85 $7.19 Million - $13.2 Million
56,967 New
56,967 $9.72 Million
Q1 2022

May 20, 2022

BUY
$126.25 - $231.85 $7.19 Million - $13.2 Million
56,967 New
56,967 $9.96 Million

Others Institutions Holding BNTX

About BioNTech SE


  • Ticker BNTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 242,684,992
  • Market Cap $26.3B
  • Description
  • BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...
More about BNTX
Track This Portfolio

Track Manufacturers Life Insurance Company, The Portfolio

Follow Manufacturers Life Insurance Company, The and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Manufacturers Life Insurance Company, The, based on Form 13F filings with the SEC.

News

Stay updated on Manufacturers Life Insurance Company, The with notifications on news.